| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 25.653 | 98.270 | 113.320 | 83.179 | 124.352 | 156.487 | 188.733 |
| Total Income - EUR | - | - | - | 25.653 | 98.270 | 113.320 | 83.179 | 151.232 | 156.487 | 207.740 |
| Total Expenses - EUR | - | - | - | 11.328 | 32.254 | 62.244 | 76.629 | 148.797 | 137.906 | 131.613 |
| Gross Profit/Loss - EUR | - | - | - | 14.325 | 66.016 | 51.076 | 6.550 | 2.435 | 18.581 | 76.126 |
| Net Profit/Loss - EUR | - | - | - | 14.069 | 65.415 | 49.961 | 5.719 | 1.191 | 17.121 | 69.894 |
| Employees | - | - | - | 0 | 5 | 4 | 5 | 9 | 8 | 5 |
Check the financial reports for the company - Robdar Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 17.397 | 16.178 | 30.679 | 30.774 | 30.680 | 91.204 |
| Current Assets | - | - | - | 16.710 | 81.722 | 124.440 | 113.590 | 112.717 | 47.176 | 138.864 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 27 | 225 | 223 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 851 | 38.558 | 34.782 |
| Cash | - | - | - | 16.710 | 81.722 | 124.440 | 113.590 | 111.839 | 8.393 | 103.858 |
| Shareholders Funds | - | - | - | 14.112 | 79.253 | 127.712 | 130.598 | 132.195 | 71.563 | 140.052 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 2.598 | 19.866 | 12.907 | 13.670 | 11.296 | 6.294 | 90.016 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Robdar Med S.r.l.